Form Health review: is it worth it?
Form Health pairs you with a board-certified obesity medicine physician and accepts most major insurance.
On this page
Physician-led GLP-1 care, not a budget script mill
Physician-led GLP-1 care, not a budget script mill
Form Health stands out among telehealth weight-loss services because it is run by physicians certified by the American Board of Obesity Medicine (ABOM), not general clinicians, and pairs every patient with a registered dietitian for ongoing behavioral support. It is genuinely useful if you have an obesity diagnosis and want medically supervised care that can be billed to most major insurers. It is overkill (and pricier) if you only want a fast, cheap GLP-1 prescription with minimal follow-up.
- May be covered by insurance
We may earn a commission if you buy through this link, at no extra cost to you. It never affects our score. How we make money
- Care is led by physicians certified by the American Board of Obesity Medicine (ABOM), a specialist credential most general telehealth weight-loss services lack
- Every patient gets a registered dietitian plus ongoing messaging, so it treats obesity as a managed condition rather than a one-time prescription
- Bills most major private insurance plans, which can cover both visits and medication and substantially cut out-of-pocket cost (Medicare coverage of the drugs is more limited)
- Prescribes a range of FDA-approved options (Wegovy, Zepbound, Saxenda, Contrave) matched to your history, not a single one-size product
- Self-pay fee is transparent at about $299/month and is HSA/FSA eligible; you can cancel anytime
- The $299/month membership does not include medications or labs, so total monthly cost can be far higher than the headline price
- Requires you to already have a primary care provider seen within the last 12 months, which excludes some prospective patients
- Multiple patient reviews report insurance-verification and billing surprises, plus weeks-long waits for initial physician and dietitian appointments
- The advertised 16% weight loss at 18 months is the company's own internal data, not an independently published clinical trial
- Medicare will not pay for a GLP-1 used solely for weight loss, and it is not the cheapest or fastest route if you simply want a low-cost prescription with minimal oversight
In-depth review
What is Form Health and how does it work?
Form Health (operated by Form Health, Inc.) is a U.S. telehealth company founded in 2019 by CEO Evan Richardson. It has raised tens of millions in venture funding — including a $12M Series A led by M13 and a $38M Series B led by Sound Ventures (2024) — and markets itself as an "obesity medicine" clinic rather than a general weight-loss app. The distinction is meaningful: the program is built around physicians certified by the American Board of Obesity Medicine (ABOM), a credential specifically focused on the medical treatment of obesity, rather than general practitioners writing GLP-1 prescriptions at volume.
The model is a longitudinal care relationship delivered entirely through the Form Health app:
- Sign up and onboarding. You download the app, complete a detailed health intake, and answer questions about weight history, medical conditions, medications, and goals.
- Care team assignment. You are matched with a Care Team that includes a clinician (an ABOM-certified physician or an advanced practice provider working under physician leadership) and a registered dietitian.
- Video visits. You have an initial evaluation followed by ongoing monthly video visits with both your clinician and your dietitian.
- Medication, if appropriate. Your clinician reviews your history and, when clinically indicated, prescribes an FDA-approved anti-obesity medication. The prescription is sent to a pharmacy; the drug itself is not dispensed by Form.
- Ongoing support. Between visits you get messaging access to your care team, plus app-based tools for weight tracking, food photo journaling, and educational content, with optional support groups and video classes.
The single most important structural fact is that Form Health is a care-and-prescribing service, not a pharmacy or a drug maker. Its value lies in the quality and continuity of the clinical relationship — specialist physicians, a dedicated dietitian, regular monitoring — while the medication is what actually drives most of the weight loss for patients who take one.
What medications does Form Health prescribe — and why "no compounding" matters?
Form Health prescribes only FDA-approved anti-obesity medications, and this is one of its clearest differentiators. Its formulary includes the injectable GLP-1 / GIP-class drugs Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide), the older injectable Saxenda (liraglutide), and the oral combination pill Contrave (naltrexone/bupropion). Which one you're prescribed depends on your medical profile, insurance coverage, and tolerance.
Critically, Form Health does not prescribe compounded semaglutide or tirzepatide. This sets it apart from many cash-pay telehealth competitors that lean heavily on cheaper compounded versions. The trade-off is real and runs both directions:
- The upside: Brand-name FDA-approved drugs have been evaluated by the FDA for safety, efficacy, and manufacturing quality. After the FDA declared the semaglutide and tirzepatide shortages resolved in 2024–2025, the legal window for mass-scale compounding of these drugs largely closed, and the FDA has repeatedly warned about dosing errors and quality risks with unapproved compounded GLP-1 products (FDA). By refusing to compound, Form sidesteps that entire category of risk.
- The downside: Brand-name GLP-1s are expensive. Without insurance coverage, list prices for Wegovy and Zepbound run well over $1,000 per month, although manufacturer self-pay programs (Lilly's LillyDirect for Zepbound vials and Novo Nordisk's NovoCare for Wegovy) have brought cash prices down substantially for single-vial purchases. The point is that Form's membership fee does not include the medication, and the drug can be the single largest line item.
If a program's main appeal to you is a low all-in cash price for a GLP-1, Form is unlikely to be the cheapest option, precisely because it won't use compounded drugs.
How well do the medications actually work?
Because Form's results are largely driven by the drugs it prescribes, the relevant evidence is the pivotal trial data for those medications — and it is strong.
- Semaglutide 2.4 mg (Wegovy): In the STEP 1 trial (NEJM 2021), adults with obesity or overweight without diabetes lost a mean of 14.9% of body weight over 68 weeks on semaglutide versus 2.4% on placebo, and 86.4% of the semaglutide group achieved at least 5% weight loss versus 31.5% on placebo (NEJM 2021).
- Tirzepatide (Zepbound): In SURMOUNT-1 (NEJM 2022), adults with obesity or overweight without diabetes lost a mean of about 15%, 19.5%, and 20.9% of body weight at the 5 mg, 10 mg, and 15 mg doses respectively over 72 weeks, versus 3.1% on placebo (NEJM 2022).
- Liraglutide (Saxenda): Produces more modest results — roughly 5–6% mean weight loss in pivotal trials — and requires a daily injection rather than weekly, which is why it has largely been superseded by the newer agents.
- Naltrexone/bupropion (Contrave): A pill option with comparatively modest efficacy (roughly 5% mean weight loss in trials) but useful for patients who can't or won't inject.
Form Health's own marketing reports patient outcomes on semaglutide (Wegovy) of roughly 6% of starting weight at 12 weeks, about 10% at 20 weeks, and about 15% at one year. These figures are broadly consistent with what the underlying GLP-1 trial data would predict for adherent patients on the more potent medications, but they are company-reported program statistics, not peer-reviewed, controlled results, so they should be read as illustrative rather than independently verified. The honest framing: the drugs are exceptionally effective in trials, and a structured program with specialist oversight plausibly improves adherence — but no telehealth company has published rigorous, controlled outcomes proving its wrapper adds a specific percentage of weight loss on top of the medication.
What does Form Health cost and what do you actually pay?
This is where prospective patients most often get confused, so it's worth being precise. There are two payment paths:
With insurance (the path Form emphasizes). Form Health is in-network with most major private insurers and accepts Medicare. When covered, your visits, labs, and medications are billed through insurance, and you pay only your normal copays and deductibles, just as you would for an in-person specialist. This is genuinely uncommon among GLP-1 telehealth companies, many of which are cash-only, and it's Form's strongest value proposition for insured patients — especially because insurance is also the only realistic way most people afford brand-name GLP-1s.
Self-pay (no coverage). If you're uninsured or your plan excludes the program, Form offers a self-pay membership of $299 per month, which is HSA/FSA eligible. This covers your clinician visits, dietitian appointments, unlimited care-team messaging, and the app. It does not cover labs or medication, both of which are billed separately. So the realistic all-in self-pay cost is $299/month plus lab fees plus whatever the drug costs you out of pocket — which, for a brand-name GLP-1 without coverage, can dwarf the membership fee.
You can cancel the membership at any time. The most common cost-related complaints in third-party reviews are limited up-front price transparency on the medication side and being asked to pay before the first clinician visit.
Is Form Health legitimate and safe?
On the legitimacy and clinical-rigor axes, Form Health is among the more credible operators in this space:
- Specialist credentialing. Care is led by ABOM-certified physicians — a real, relevant board certification — rather than anonymous prescribers.
- Dietitian inclusion. A registered dietitian is part of standard care, not an upsell, which aligns with clinical guidelines that pair anti-obesity medication with nutrition and lifestyle support.
- No compounded drugs. Sticking to FDA-approved medications removes a significant safety and regulatory gray zone.
- Insurance and Medicare participation. Being credentialed with payers requires meeting their standards and implies real medical billing infrastructure, not a pure cash storefront.
- Coordination-of-care requirement. Form requires that you have a primary care physician and have seen them within the last 12 months, which is the responsible posture for a specialty clinic and reduces the "prescribe in a vacuum" risk seen elsewhere.
What to still watch for: as with any telehealth weight program, you should confirm the clinician's licensing in your state, understand the lab monitoring schedule, disclose all medications (GLP-1s have meaningful interactions and contraindications, including a boxed warning for medullary thyroid carcinoma and MEN 2 with the GLP-1 class), and not treat the convenience of telehealth as a reason to skip in-person care for unrelated issues.
Who should sign up — and eligibility
To enroll you must be 18 or older with a BMI of 30 or greater, or 27 or greater with a weight-related condition such as type 2 diabetes, hypertension, or high cholesterol — the same thresholds used in the FDA labels for these medications and in obesity-medicine guidelines. You also need an established primary care physician seen within the past year.
Form Health is a strong fit if you:
- Have insurance or Medicare that may cover obesity treatment — this is where Form's model shines.
- Want genuine specialist care (ABOM physician plus dietitian) and ongoing monitoring rather than a one-and-done prescription.
- Specifically want brand-name, FDA-approved GLP-1 medication and want to avoid compounded products.
- Have a higher BMI or weight-related comorbidities and intend to treat obesity as a long-term medical condition.
You should probably skip it if you:
- Are uninsured and your main goal is the cheapest possible GLP-1 — the no-compounding policy plus the $299 membership makes Form one of the pricier cash routes.
- Want quick, light-touch access without monthly video visits.
- Don't meet the BMI/comorbidity criteria, or want a program that will prescribe without coordinating with a primary care doctor.
How does Form Health compare to alternatives?
- vs. cash-pay GLP-1 startups (e.g., Hims, Henry Meds, Found): Those often offer lower headline prices, frequently using compounded medication, with lighter-touch clinical contact. Form trades that low price for specialist physicians, included dietitian care, insurance billing, and FDA-approved-only drugs. If price is paramount, the others may win; if clinical rigor and brand-name medication matter most, Form is stronger.
- vs. Calibrate: Calibrate is the closest philosophical competitor — a structured, coaching-heavy, year-long metabolic program. Form leans more medical (physician-led, insurance/Medicare-billing) where Calibrate leans more behavioral/coaching, and Calibrate has historically been cash-pay.
- vs. your own doctor + a pharmacy: If you already have a primary care physician or endocrinologist willing to manage anti-obesity medication and your insurance covers the drug, you may not need Form at all. Form's advantage is concentrated specialist expertise and a structured program for people whose regular doctor won't or can't provide dedicated obesity care.
The bottom line
Form Health is one of the more clinically serious players in online weight care: ABOM-certified physicians, a registered dietitian built into standard care, insurance and Medicare billing, a primary-care-coordination requirement, and a firm policy of prescribing only FDA-approved, brand-name medications. Those choices make it safer and more credible than many cash-pay GLP-1 mills — and they make it a particularly good fit for insured or Medicare patients who want to treat obesity as the chronic medical condition it is.
The honest caveats are about cost and proof. The $299 self-pay membership does not include the medication, and Form's no-compounding stance means brand-name GLP-1s can be very expensive without insurance, so verify your coverage before assuming a manageable price. And while the underlying drugs have outstanding trial data (NEJM 2021; NEJM 2022), Form's own patient outcomes (around 15% at one year on semaglutide) are self-reported program figures rather than independently published, controlled evidence that its model adds measurable weight loss beyond the medication itself. Bottom line: if you value clinical rigor and have coverage, Form Health is a top-tier choice; if you're uninsured and chasing the lowest possible price, look elsewhere.
How it works
Form Health is a telehealth obesity clinic, not a drug itself. After an online intake, you are matched with a care team led by an ABOM-certified obesity-medicine physician (or advanced practice provider) plus a registered dietitian. They review your history and, when medically appropriate, prescribe FDA-approved anti-obesity medications such as Wegovy (semaglutide), Zepbound (tirzepatide), Saxenda (liraglutide), or Contrave. Most of these are GLP-1-based drugs that mimic gut hormones to slow stomach emptying, reduce appetite, and curb cravings (tirzepatide also acts on the GIP receptor). Care is delivered through video visits, unlimited messaging, and an app for weight and food tracking, combining medication with nutrition and behavior change.
Active ingredient: Brand-name GLP-1 (Wegovy, Zepbound, etc.)
Effectiveness
Form Health reports an average of 16% body-weight loss at 18 months across its patients (with and without medication), but this is the company's own internal program data, not an independently published, peer-reviewed clinical trial, so treat it as a marketing claim rather than proof. The medications Form prescribes do have strong trial evidence. In the STEP-1 trial (NEJM, 2021), adults on weekly semaglutide 2.4 mg (Wegovy) lost an average of about 14.9% of body weight at 68 weeks versus 2.4% on placebo. In SURMOUNT-1 (NEJM, 2022), tirzepatide (Zepbound) produced average losses of roughly 15% to 21% over 72 weeks depending on dose (about 15.0% at 5 mg up to 20.9% at 15 mg in the primary analysis, and higher, up to about 22.5%, among adherent participants). Real-world telehealth outcomes are often somewhat lower than trial figures because of drug discontinuation and adherence.
What to expect over time
A realistic timeline of what Form Health users typically experience. Individual results vary; this is educational, not medical advice.
- Day 1 (Signup & onboarding)
You create an account, download the app, and complete an online onboarding survey covering medical history, current medications, and past weight-loss attempts. You then schedule your first video visit. Form is insurance-based ($99/mo with eligible insurance, $299/mo self-pay); it does not require you to switch pharmacies.
- Week 1-2 (Intake visit & labs)
You meet your dedicated Care Team (an ABOM-certified physician or advanced-practice provider plus a registered dietitian) for a thorough video evaluation. They review your history, labs, and goals to build a personalized plan. If you qualify (typically BMI 30+, or 27+ with a weight-related condition) and it's appropriate, an FDA-approved GLP-1 such as Wegovy, Zepbound, or Ozempic may be prescribed.
- Week 2-4 (Prior authorization & first fills)
Form submits any required prior authorization to your insurer, which can take days to a few weeks and may need appeals. Once approved, you fill the prescription at your own pharmacy. GLP-1s start at a low dose (e.g., semaglutide 0.25 mg weekly) that is intentionally below the therapeutic range; its job is to let your body adjust with minimal nausea, so meaningful weight loss is not expected yet.
- Month 1-4 (Dose titration)
Your clinician steps the dose up roughly every 4 weeks (semaglutide: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) to reach a maintenance dose around week 17. GI side effects like nausea, constipation, or diarrhea are most common early and around each increase, and usually ease over time. Appetite reduction and gradual, steady weight loss typically begin during this phase, alongside nutrition and behavior coaching with your dietitian.
- Month 4-12 (Steady progress on maintenance dose)
Once at the maintenance dose, weight loss continues gradually over months rather than all at once. You have regular (often monthly) video check-ins plus unlimited messaging to adjust the plan and manage side effects. Results vary widely by individual, dose tolerated, adherence, and biology; in the STEP 1 trial, average loss was about 15% of body weight at 68 weeks, but individual outcomes differ.
- Month 12-18+ (Sustained results & long-term care)
Form reports an average of about 16% of body weight lost at 18 months across its patients. GLP-1 treatment is generally long-term: stopping medication often leads to regained weight, so the plan emphasizes ongoing medical supervision, nutrition, and behavior change to maintain results. There is no fixed end date; care continues as long as it's medically appropriate.
Side effects
Side effects come from the prescribed medication, not the service itself. The most common with GLP-1 drugs (Wegovy, Zepbound, Saxenda) are gastrointestinal: nausea, diarrhea, vomiting, constipation, and abdominal discomfort, usually mild-to-moderate and worst during dose escalation. Contrave can cause nausea, headache, constipation, insomnia, and raised blood pressure. Serious but uncommon risks include acute pancreatitis, gallbladder disease, and kidney injury from dehydration. GLP-1 drugs carry an FDA boxed warning for thyroid C-cell tumors seen in rodents and are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. Seek prompt medical care for severe, persistent abdominal pain.
Cost
Starts at $299/mo from Form Health.
As of 2026, Form Health's self-pay membership is about $299/month, which is HSA/FSA-eligible and covers physician and dietitian visits, messaging, and the app, but not medications or lab work. GLP-1 drugs can cost roughly $500 to $1,300 or more per month at cash price (manufacturer savings programs and lower-cost direct-pay vials for Wegovy and Zepbound can reduce this). Alternatively, Form can bill visits, labs, and medications through most major private insurance plans, in which case you pay only copays and deductibles, which can dramatically lower total cost. Medicare is more limited: by federal law it does not cover a drug prescribed solely for weight loss, so a GLP-1 is generally covered only when prescribed for a separate approved indication such as type 2 diabetes or cardiovascular risk reduction. Coverage varies widely by plan, so verify your specific benefits in writing before starting.
formhealth.co FAQ (checked Sept 15, 2026): self-pay $299/month for clinician visits, registered-dietitian appointments, unlimited messaging and the platform; medication and labs are separate.
Prices current as of May 29, 2026 and exclude promo codes; cash-pay and channel pricing change frequently — confirm with the pharmacy or provider.
Is it worth it?
If you want obesity treated as a chronic medical condition with specialist oversight, dietitian coaching, and the ability to bill most private insurers, Form Health is one of the more credible options. The main drawbacks are a $299/month fee that does not include drugs or labs, the requirement to already have a primary care provider, and repeated patient complaints about insurance-verification surprises and scheduling waits. Medicare coverage is limited, because federal law excludes drugs used solely for weight loss. Confirm your coverage in writing before you start, and treat this as general information, not medical advice.
Frequently asked questions
Is Form Health legit?
Yes. Form Health is an established US telehealth obesity clinic founded in 2019, staffed by physicians certified by the American Board of Obesity Medicine and by registered dietitians, and backed by venture funding. It holds an A- Better Business Bureau rating and a roughly 4.4-star Trustpilot rating across hundreds of reviews, though some complaints cite billing and scheduling issues.
How much does Form Health cost per month?
As of 2026, Form Health's self-pay membership is about $299 per month, covering physician and dietitian visits, messaging, and the app. Medications and lab work cost extra. If you use insurance, you instead pay applicable copays and deductibles, which can be much lower; the self-pay fee is HSA/FSA eligible.
Does Form Health take insurance and Medicare?
Form Health bills visits, labs, and medications through most major private insurance plans, and you pay only your copay or deductible. Medicare is more limited: federal law bars Medicare from covering a drug used solely for weight loss, so a GLP-1 is generally covered only when prescribed for a separate approved indication such as type 2 diabetes or cardiovascular risk reduction. Verify your specific benefits in writing before you start.
What medications does Form Health prescribe?
Form Health prescribes FDA-approved anti-obesity medications, including the GLP-1 injectables Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide), plus the oral pill Contrave. The physician selects the medication based on your medical history when treatment is appropriate.
Do I need a primary care doctor to use Form Health?
Yes. Form Health requires that you have a primary care provider and have seen them within the past 12 months. Form coordinates with your PCP rather than replacing them, so you must establish primary care before or alongside starting the program.
Who qualifies for Form Health?
US adults 18 and older with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol. People who are pregnant or breastfeeding, those seeking eating-disorder treatment, or anyone with contraindications to the medications are not candidates.
How much weight can you lose with Form Health?
Form Health reports an average of about 16% body-weight loss at 18 months across its patients, though this is internal company data, not a peer-reviewed trial. The GLP-1 drugs it prescribes produced roughly 15% (semaglutide, STEP-1) to about 21% (tirzepatide at the highest dose, SURMOUNT-1) average loss in published clinical trials. Individual results vary, and real-world losses are often lower.
Can I cancel Form Health anytime?
Yes. Form Health states you can cancel your membership at any time, and the care team helps create a transition plan. Confirm any billing-cycle details directly with their care advisors so you are not charged for an additional month.
Sources
- How Form Health Works | Medical Weight Loss Treatment — Form Health (manufacturer/provider clinical page) (2026)
- Twelve-month analysis of real-world evidence from a telehealth obesity-treatment provider using antiobesity medications — Obesity (Silver Spring); 32(12):2246-2254 (Ard JD et al.; WW/Form telehealth clinic real-world data) DOI:10.1002/oby.24169 (2024)
- Twelve-month analysis of real-world evidence from a telehealth obesity-treatment provider using antiobesity medications (full text) — Obesity (Silver Spring), PubMed Central (2024)
- WEGOVY (semaglutide) injection/tablet - FDA Prescribing Information — DailyMed, U.S. National Library of Medicine (Novo Nordisk label) (2026)
- WEGOVY (semaglutide) injection, for subcutaneous use - Highlights of Prescribing Information — U.S. Food and Drug Administration (Drugs@FDA) (2025)
- ZEPBOUND (tirzepatide) injection - FDA Prescribing Information — DailyMed, U.S. National Library of Medicine (Eli Lilly label) (2025)
- FDA Approves New Medication for Chronic Weight Management (Zepbound/tirzepatide) — U.S. Food and Drug Administration (2023)
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — New England Journal of Medicine; 384(11):989-1002 (Wilding JPH et al.) DOI:10.1056/NEJMoa2032183 (2021)
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — New England Journal of Medicine; 387(3):205-216 (Jastreboff AM et al.) (2022)
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE Obesity and Prediabetes) — New England Journal of Medicine; 373(1):11-22 (Pi-Sunyer X et al.) DOI:10.1056/NEJMoa1411892 (2015)
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) — New England Journal of Medicine; 389(24):2221-2232 (Lincoff AM et al.) (2023)
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline — Journal of Clinical Endocrinology & Metabolism; 100(2):342-362 (Apovian CM et al.) DOI:10.1210/jc.2014-3415 (2015)
- AACE/ACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity — Endocrine Practice; 22(Suppl 3):1-203 (Garvey WT et al.) (2016)
- Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss (FDA concerns with unapproved/compounded GLP-1 drugs) — U.S. Food and Drug Administration (2025)
Ready to try Form Health?
Check eligibility & price — from $299/mo- May be covered by insurance
Affiliate link — we may earn a commission at no extra cost to you, and it never changes our rankings or score. Disclosure
Ways to save on Form Health
Legitimate ways to lower your cost. We don’t sell Form Health — this is independent guidance, not medical or financial advice. Confirm current terms with the program and your clinician.
- Manufacturer savings program
Many brand-name drugs have a manufacturer copay-savings program on the drug’s official site. Check the maker’s website for a current savings card (commercial insurance usually required; government insurance excluded).
- Patient assistance programs (PAPs)
If you’re uninsured or low-income, free or reduced-cost medication may be available through patient assistance programs. Search MedicineAssistanceTool (PhRMA) and NeedyMeds.
- Ask about a 90-day supply
Filling a 90-day supply instead of monthly often lowers the per-month cost and cuts pharmacy trips. Ask your prescriber and pharmacy whether it’s an option for you.
How Form Health compares
Same-category options, scored on the same six-axis rubric. Higher is better.
| F | Form Healththis reviewPrescription | 8.6/10 | — |
| P | PlushCare Weight LossPrescription | 7.5/10 | Read → |